Global Retinal Disease Therapeutics Market Research Report 2023

Report ID: 1891823 | Published Date: Oct 2024 | No. of Page: 83 | Base Year: 2023 | Rating: 4.2 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Retinal Disease Therapeutics Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Macular Degeneration
        1.2.3 Diabetic Macular Edema
        1.2.4 Diabetic Retinopathy
        1.2.5 Retinal Vein Occlusion
    1.3 Market by Application
        1.3.1 Global Retinal Disease Therapeutics Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospital Pharmacy
        1.3.3 Retail Pharmacy
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Retinal Disease Therapeutics Market Perspective (2017-2028)
    2.2 Retinal Disease Therapeutics Growth Trends by Region
        2.2.1 Retinal Disease Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Retinal Disease Therapeutics Historic Market Size by Region (2017-2022)
        2.2.3 Retinal Disease Therapeutics Forecasted Market Size by Region (2023-2028)
    2.3 Retinal Disease Therapeutics Market Dynamics
        2.3.1 Retinal Disease Therapeutics Industry Trends
        2.3.2 Retinal Disease Therapeutics Market Drivers
        2.3.3 Retinal Disease Therapeutics Market Challenges
        2.3.4 Retinal Disease Therapeutics Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Retinal Disease Therapeutics Players by Revenue
        3.1.1 Global Top Retinal Disease Therapeutics Players by Revenue (2017-2022)
        3.1.2 Global Retinal Disease Therapeutics Revenue Market Share by Players (2017-2022)
    3.2 Global Retinal Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Retinal Disease Therapeutics Revenue
    3.4 Global Retinal Disease Therapeutics Market Concentration Ratio
        3.4.1 Global Retinal Disease Therapeutics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Retinal Disease Therapeutics Revenue in 2021
    3.5 Retinal Disease Therapeutics Key Players Head office and Area Served
    3.6 Key Players Retinal Disease Therapeutics Product Solution and Service
    3.7 Date of Enter into Retinal Disease Therapeutics Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Retinal Disease Therapeutics Breakdown Data by Type
    4.1 Global Retinal Disease Therapeutics Historic Market Size by Type (2017-2022)
    4.2 Global Retinal Disease Therapeutics Forecasted Market Size by Type (2023-2028)
5 Retinal Disease Therapeutics Breakdown Data by Application
    5.1 Global Retinal Disease Therapeutics Historic Market Size by Application (2017-2022)
    5.2 Global Retinal Disease Therapeutics Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Retinal Disease Therapeutics Market Size (2017-2028)
    6.2 North America Retinal Disease Therapeutics Market Size by Country (2017-2022)
    6.3 North America Retinal Disease Therapeutics Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Retinal Disease Therapeutics Market Size (2017-2028)
    7.2 Europe Retinal Disease Therapeutics Market Size by Country (2017-2022)
    7.3 Europe Retinal Disease Therapeutics Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Retinal Disease Therapeutics Market Size (2017-2028)
    8.2 Asia-Pacific Retinal Disease Therapeutics Market Size by Country (2017-2022)
    8.3 Asia-Pacific Retinal Disease Therapeutics Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Retinal Disease Therapeutics Market Size (2017-2028)
    9.2 Latin America Retinal Disease Therapeutics Market Size by Country (2017-2022)
    9.3 Latin America Retinal Disease Therapeutics Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Retinal Disease Therapeutics Market Size (2017-2028)
    10.2 Middle East & Africa Retinal Disease Therapeutics Market Size by Country (2017-2022)
    10.3 Middle East & Africa Retinal Disease Therapeutics Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Merck
        11.1.1 Merck Company Detail
        11.1.2 Merck Business Overview
        11.1.3 Merck Retinal Disease Therapeutics Introduction
        11.1.4 Merck Revenue in Retinal Disease Therapeutics Business (2017-2022)
        11.1.5 Merck Recent Development
    11.2 Novartis
        11.2.1 Novartis Company Detail
        11.2.2 Novartis Business Overview
        11.2.3 Novartis Retinal Disease Therapeutics Introduction
        11.2.4 Novartis Revenue in Retinal Disease Therapeutics Business (2017-2022)
        11.2.5 Novartis Recent Development
    11.3 Allergan
        11.3.1 Allergan Company Detail
        11.3.2 Allergan Business Overview
        11.3.3 Allergan Retinal Disease Therapeutics Introduction
        11.3.4 Allergan Revenue in Retinal Disease Therapeutics Business (2017-2022)
        11.3.5 Allergan Recent Development
    11.4 Roche
        11.4.1 Roche Company Detail
        11.4.2 Roche Business Overview
        11.4.3 Roche Retinal Disease Therapeutics Introduction
        11.4.4 Roche Revenue in Retinal Disease Therapeutics Business (2017-2022)
        11.4.5 Roche Recent Development
    11.5 Regeneron
        11.5.1 Regeneron Company Detail
        11.5.2 Regeneron Business Overview
        11.5.3 Regeneron Retinal Disease Therapeutics Introduction
        11.5.4 Regeneron Revenue in Retinal Disease Therapeutics Business (2017-2022)
        11.5.5 Regeneron Recent Development
    11.6 Santen
        11.6.1 Santen Company Detail
        11.6.2 Santen Business Overview
        11.6.3 Santen Retinal Disease Therapeutics Introduction
        11.6.4 Santen Revenue in Retinal Disease Therapeutics Business (2017-2022)
        11.6.5 Santen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Retinal Disease Therapeutics Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Macular Degeneration
    Table 3. Key Players of Diabetic Macular Edema
    Table 4. Key Players of Diabetic Retinopathy
    Table 5. Key Players of Retinal Vein Occlusion
    Table 6. Global Retinal Disease Therapeutics Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Retinal Disease Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Retinal Disease Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 9. Global Retinal Disease Therapeutics Market Share by Region (2017-2022)
    Table 10. Global Retinal Disease Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 11. Global Retinal Disease Therapeutics Market Share by Region (2023-2028)
    Table 12. Retinal Disease Therapeutics Market Trends
    Table 13. Retinal Disease Therapeutics Market Drivers
    Table 14. Retinal Disease Therapeutics Market Challenges
    Table 15. Retinal Disease Therapeutics Market Restraints
    Table 16. Global Retinal Disease Therapeutics Revenue by Players (2017-2022) & (US$ Million)
    Table 17. Global Retinal Disease Therapeutics Market Share by Players (2017-2022)
    Table 18. Global Top Retinal Disease Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Retinal Disease Therapeutics as of 2021)
    Table 19. Ranking of Global Top Retinal Disease Therapeutics Companies by Revenue (US$ Million) in 2021
    Table 20. Global 5 Largest Players Market Share by Retinal Disease Therapeutics Revenue (CR5 and HHI) & (2017-2022)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Retinal Disease Therapeutics Product Solution and Service
    Table 23. Date of Enter into Retinal Disease Therapeutics Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Retinal Disease Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 26. Global Retinal Disease Therapeutics Revenue Market Share by Type (2017-2022)
    Table 27. Global Retinal Disease Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 28. Global Retinal Disease Therapeutics Revenue Market Share by Type (2023-2028)
    Table 29. Global Retinal Disease Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 30. Global Retinal Disease Therapeutics Revenue Market Share by Application (2017-2022)
    Table 31. Global Retinal Disease Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 32. Global Retinal Disease Therapeutics Revenue Market Share by Application (2023-2028)
    Table 33. North America Retinal Disease Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 34. North America Retinal Disease Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Europe Retinal Disease Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 36. Europe Retinal Disease Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Asia-Pacific Retinal Disease Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 38. Asia-Pacific Retinal Disease Therapeutics Market Size by Region (2023-2028) & (US$ Million)
    Table 39. Latin America Retinal Disease Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Latin America Retinal Disease Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Middle East & Africa Retinal Disease Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Middle East & Africa Retinal Disease Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Merck Company Detail
    Table 44. Merck Business Overview
    Table 45. Merck Retinal Disease Therapeutics Product
    Table 46. Merck Revenue in Retinal Disease Therapeutics Business (2017-2022) & (US$ Million)
    Table 47. Merck Recent Development
    Table 48. Novartis Company Detail
    Table 49. Novartis Business Overview
    Table 50. Novartis Retinal Disease Therapeutics Product
    Table 51. Novartis Revenue in Retinal Disease Therapeutics Business (2017-2022) & (US$ Million)
    Table 52. Novartis Recent Development
    Table 53. Allergan Company Detail
    Table 54. Allergan Business Overview
    Table 55. Allergan Retinal Disease Therapeutics Product
    Table 56. Allergan Revenue in Retinal Disease Therapeutics Business (2017-2022) & (US$ Million)
    Table 57. Allergan Recent Development
    Table 58. Roche Company Detail
    Table 59. Roche Business Overview
    Table 60. Roche Retinal Disease Therapeutics Product
    Table 61. Roche Revenue in Retinal Disease Therapeutics Business (2017-2022) & (US$ Million)
    Table 62. Roche Recent Development
    Table 63. Regeneron Company Detail
    Table 64. Regeneron Business Overview
    Table 65. Regeneron Retinal Disease Therapeutics Product
    Table 66. Regeneron Revenue in Retinal Disease Therapeutics Business (2017-2022) & (US$ Million)
    Table 67. Regeneron Recent Development
    Table 68. Santen Company Detail
    Table 69. Santen Business Overview
    Table 70. Santen Retinal Disease Therapeutics Product
    Table 71. Santen Revenue in Retinal Disease Therapeutics Business (2017-2022) & (US$ Million)
    Table 72. Santen Recent Development
    Table 73. Research Programs/Design for This Report
    Table 74. Key Data Information from Secondary Sources
    Table 75. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Retinal Disease Therapeutics Market Share by Type: 2021 VS 2028
    Figure 2. Macular Degeneration Features
    Figure 3. Diabetic Macular Edema Features
    Figure 4. Diabetic Retinopathy Features
    Figure 5. Retinal Vein Occlusion Features
    Figure 6. Global Retinal Disease Therapeutics Market Share by Application in 2021 & 2028
    Figure 7. Hospital Pharmacy Case Studies
    Figure 8. Retail Pharmacy Case Studies
    Figure 9. Others Case Studies
    Figure 10. Retinal Disease Therapeutics Report Years Considered
    Figure 11. Global Retinal Disease Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 12. Global Retinal Disease Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Retinal Disease Therapeutics Market Share by Region: 2021 VS 2028
    Figure 14. Global Retinal Disease Therapeutics Market Share by Players in 2021
    Figure 15. Global Top Retinal Disease Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Retinal Disease Therapeutics as of 2021)
    Figure 16. The Top 10 and 5 Players Market Share by Retinal Disease Therapeutics Revenue in 2021
    Figure 17. North America Retinal Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. North America Retinal Disease Therapeutics Market Share by Country (2017-2028)
    Figure 19. United States Retinal Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Canada Retinal Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Retinal Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Retinal Disease Therapeutics Market Share by Country (2017-2028)
    Figure 23. Germany Retinal Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. France Retinal Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. U.K. Retinal Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Italy Retinal Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Russia Retinal Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Nordic Countries Retinal Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Asia-Pacific Retinal Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Asia-Pacific Retinal Disease Therapeutics Market Share by Region (2017-2028)
    Figure 31. China Retinal Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Japan Retinal Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. South Korea Retinal Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Southeast Asia Retinal Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. India Retinal Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Australia Retinal Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Latin America Retinal Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Latin America Retinal Disease Therapeutics Market Share by Country (2017-2028)
    Figure 39. Mexico Retinal Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Brazil Retinal Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Middle East & Africa Retinal Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Middle East & Africa Retinal Disease Therapeutics Market Share by Country (2017-2028)
    Figure 43. Turkey Retinal Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Saudi Arabia Retinal Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Merck Revenue Growth Rate in Retinal Disease Therapeutics Business (2017-2022)
    Figure 46. Novartis Revenue Growth Rate in Retinal Disease Therapeutics Business (2017-2022)
    Figure 47. Allergan Revenue Growth Rate in Retinal Disease Therapeutics Business (2017-2022)
    Figure 48. Roche Revenue Growth Rate in Retinal Disease Therapeutics Business (2017-2022)
    Figure 49. Regeneron Revenue Growth Rate in Retinal Disease Therapeutics Business (2017-2022)
    Figure 50. Santen Revenue Growth Rate in Retinal Disease Therapeutics Business (2017-2022)
    Figure 51. Bottom-up and Top-down Approaches for This Report
    Figure 52. Data Triangulation
    Figure 53. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Merck
Novartis
Allergan
Roche
Regeneron
Santen
Frequently Asked Questions
Retinal Disease Therapeutics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Retinal Disease Therapeutics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Retinal Disease Therapeutics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports